# clm_3A63F9598C82

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 10,125,500,000 United States dollar  
valid_from: 2020-09-30  
valid_to: 2020-12-31  
published: 2020-11-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_155A4F299072  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 10,125,500,000 United States dollar", as of 2020-09-30 (until 2020-12-31). Claim clm_3A63F9598C82, https://asof.is/claim/clm_3A63F9598C82, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2020, filed 2020-11-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422020000030/0001804220-20-000030-index.htm (primary, SEC EDGAR 10-Q Q3 FY2020, published 2020-11-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 9,057,400,000 United States dollar | valid 2020-06-30 to 2020-09-30 | conf 0.95 | superseded | superseded_by [clm_3A63F9598C82](/claim/clm_3A63F9598C82.md) | [clm_2CC38605C128](/claim/clm_2CC38605C128.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.